Sclerocarya birrea is a medicinal plant used for the treatment of inflammatory-and bacterial-related diseases. The present study investigated in vitro and in vivo the effects of the stem bark methanol extract of S. birrea. Nitrite, TNF, IL-lP, IL-6 and IL-12p40 production by bone marrow-derived macrophages (BMDM) pre-incubated with or without S. birrea, and stimulated with Lipopolysaccharide (LPS) or infected with live Mycobacterium bovis Bacillus Calmette Guerin (BCG) was evaluated. S. birrea extract inhibited, in a concentration-dependent manner, nitrite, TNF, IL-lP, IL-6 and IL-12p40 production by BMDM stimulated with LPS or infected with live BCG. The iNOS expression was reduced by S. birrea after stimulation of BMDM with LPS. In addition, S. birrea inhibited the nuclear factor KB (NF-KB) activation by both LPS and BCG. The effects ofthe plant extract were also evaluated in an in vivo model of liver injury induced by D-galactosamine/LPS (D-GaINILPS) administration in mice. S. birrea limited D-GaIN/LPS-liver injury as assessed by a reduction in transaminases and TNF, IL-lP, IL-6 serum levels, and translocation of NF-KB to the nucleus. Taken together, our data indicate that stem bark methanol extract of S. birrea possesses anti-inflammatory properties by inhibiting NF -KB activation and cytokine release induced by inflammatory or infectious stimuli.
bark and kernel oil cake revealed that the bark has the highest amount of phenolic compounds including flavonoids and tannins, also present in the fruits (3) . S. birrea bark contains 10-20% tannins, trace alkaloids and possesses antioxidant activity (4) . Furthermore, animal studies have shown anti-diabetic (5) (6) , and anti-convulsivant effects of S. birrea stem bark (7) . This part of the plant also inhibited egg albumin-induced paw oedema in rats (8) and growth of some bacterial species (Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Enterococcus faecalis) (9) . However, the antiinflammatory and anti-bacterial effects of this plant are not sufficiently explored.
Endotoxins and other bacterial products stimulate the innate immune system of a host and the release of inflammatory molecules, such as cytokines and chemokines, as response to infections. Lipopolysaccharide (LPS) or endotoxin, a major component of the outer membrane of Gram-negative bacteria, activates macrophages through Toll-like receptor 4 and induces the secretion of NO and cytokines such as tumor necrosis factor alpha (TNF or TNF-a), IL-l~, IL-6 and IL-12 (10) (11) (12) . These inflammatory molecules are the major cause of the various signs and symptoms that occur during bacterial infections, including fever, inflammation and acute phase responses.
In the present study, we examine the effects of the stem bark methanol extract of S. birrea in vitro on pro-inflammatory cytokine production by bone marrow-derived macrophages (BMDM) stimulated with LPS or infected with live Mycobacterium bovis BCG, and in vivo in mice with D-galactosamine /lipopolysaccharide (D-GaIN/LPS)-induced hepatic failure. The plant extract inhibited pro-inflammatory cytokine production and NF-ill nuclear translocation by BMDM stimulated with LPS or infected with live M bovis BCG and reduced D-GaIN/LPS-induced hepatic injury induced in mice by limiting NF-KB and cytokine activation.
MATERIALS AND METHODS

Plant materials
The fresh stem bark of Sclerocarya birrea was harvested in Maroua, (North Cameroon) in June 2005 and identified in the National Herbarium, Yaounde, Cameroon by comparison to an existing voucher specimen No. 7770.
Two kilograms of the air-dried powdered bark were macerated in methanol for 72 h. The mixture was filtered using Whatman No. 1 filter paper and then concentrated under reduced pressure to obtain 90 g (yield: 4.5%) of a brown solid, representing the stem bark methanol extract of Sclerocarya birrea (S. birrea). For the in vitro experiments, 250 mg of the plant extract were dissolved in 10 ml of Dulbecco's Modified Eagle's Medium (DMEM). For in vivo studies, 240 mg of the plant extract were dissolved in 20 ml of distilled water. The obtained solutions were stored at -20°C until used.
Bone marrow-derived macrophage (BMDM) cultures and treatment with S. birrea followed by LPS stimulation or M bovis BeG infection
Murine bone marrow cells were differentiated into macrophages after culturing at 1.5 x 10 6 cells/well in 24 well plates in DMEM supplemented with 10% fetal calf serum and 20% L929 cell-conditioned medium as a source of granulocyte-macrophage colony-stimulating factor. After 6 days of culture, the cell preparation contained 99% of adherent macrophages (13) which represented about 10% of total cells initially put into culture. BMDM were treated or not with various concentrations (12.5, 25 and 50 ug/ml) of the stem bark methanol extract of S. birrea for 30 min. BMDM were then stimulated with Escherichia coli (serotype 055:B5) LPS (I ug/ml) for 24 h or infected with live M bovis BCG (5 x 10 4/well) for 4 days. The supernatant was harvested for nitrite and cytokine determination.
TNF, IL-l~, IL-6 and IL-12p40 evaluation in cell culture supernatant and mouse sera
The amounts ofTNF, IL-l~, IL-6 and IL-12p40 in the cell-culture supernatant and mouse sera were assessed using enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions (14) .
Nitrite determination
Nitrite accumulation in BMDM culture medium was measured as an indicator of NO production by Griess reagent (I % sulphanilamide and 0.1% naphtylethylenediamide in 2.5% phosphoric acid). In brief, the cultured supernatant (50 ul) was mixed with 50 ul of Griess reagent for 5 min. The absorbance was measured at 570 nm and nitrite concentration was determined by comparison with reference to a sodium nitrite standard curve (15) .
Immunofluorescence and immunohistochemistry studies
BMDM were incubated with S. birrea (50 ug/ml) for 30 min and stimulated with LPS for 1 hand 12 h for NF-KB activation and iNOS expression, respectively. Cells were then fixed with 4% paraformaldehyde for 30 minutes, rinsed with PBS, permeabilized with 0.1% Triton in PBS for 30 minutes, washed with PBS and blocked for 30 minutes at room temperature with I% bovine serum albumin in PBS. BMDM were then incubated with the primary antibody (rabbit anti-mouse p65 subunit of NF-KB, sc-375, Santa Cruz Biotechnology, I :200; or rabbit anti-mouse iNOS, Calbiochem, I :500) for 2 h, followed by the secondary antibody (goat anti-rabbit IgG-FITC, Southern Biotechnology Associates, I :500) for I h at room temperature and finally, examined with fluorescence microscopy.
Immunohistochemistry on liver tissues was carried out as previously reported (15) using anti-rabbit anti-mouse p65 subunit ofNF-KB and anti-iNOS antibodies.
Crystal violet assay for cell viability
Cells were washed with PBS, stained with 0.4% crystal violet solution in methanol for 10 min, washed with water and dried, and the absorbance at 570 nm was measured by a microplate reader as reported in (16) .
Cellular fractionation and western blot analysis
RAW264.7 murine macrophages and BMDM cells treated or not with S. Birrea (30 minutes), were incubated with either LPS or BCG. Nuclear and cytoplasmic proteins were extracted using a modified protocol based on that previously described (17) . Briefly, cells were Iyzed by incubation in TKM buffer (50 mM Tris-HCI (pH 7.4), 25 mM KCI, 5 mM MgCl z ' and I mM EGTA) containing 1% TX-IOO, plus protease inhibitors (10 mM leupeptin, 2.5 mM aprotinin, and 2 mM Pefabloc) 30 minutes on ice, sonication 2 minutes, followed by a centrifugation at 5000 g for 30 minutes and separation of the pellet (nuclear proteins) and the supernatant (cytoplasmic proteins), and western blot as previously described (15, 17) . Primary antibody was a polyclonal rabbit anti-mouse NFKB p65 (Santa Cruz biotechnology, I :500 dilution). A rabbit polyclonal anti-actin was used as control antibody. Goat anti-rabbit HRP was the second antibody (Bio-Rad, Hercules, CA; I :5000 dilution). Blots were developed with an ECL kit (Amersham Biosciences, UK).
Mouse model of D-galactosamine/Lipopolysaccharide (D-GaIN/LPS)-induced hepatic injury in mice
Male and female BALB/c mice (20-22 g, 8-12 weeks old) were used for the investigations. The animals were housed in standard environmental conditions with free access to a standard commercial diet and water ad libidum. The mice were divided into groups of six. Sclerocarya birrea preparations were administered orally (150 or 300 mg/kg) to mice at I and 12 h before D-GaIN/LPS administration. The mice in the control group received distilled water. One hour after the second treatment with S. birrea extract or vehicle, mice received an intraperitoneal injection of D-GaIN (10 mg/animal), immediately followed by intraperitoneal injection of LPS (0.1 ug/g body weight). Blood samples were obtained from retro-orbital sinuses 2 and 6 h after administration of D-GaIN/LPS. Liver samples obtained 6 h after the D-GaIN/LPS injection were fixed in 4% formaldehyde and embedded in paraffin for hematoxylin/eosin staining (H & E). A second group of 6 mice, separated into two groups and treated in similar conditions, were sacrificed I h after LPS for liver immunohistochemistry analysis.
Serum transaminase content
Hepatocyte damage was assessed by measuring serum enzyme activities of aspartate aminotrasferase (AST) and alanine aminotrasferase (ALT) using an automated Synchron LX20 Beckman-Coulter following the IFCC procedure as reported (18) .
Statistical analysis
Statistical differences were determined by paired Student's t test, and p-values less than 0.05 were considered statistically significant.
RESULTS
S. birrea extract inhibitedpro-inflammatory cytokine production by BMDM stimulated with LPS or infected with live M bovis BCG
To analyse the effects of S. birrea on BMDM stimulated with LPS, cells were incubated with the plant extract, stimulated or not with LPS and supernatants harvested 24 h later for cytokine determination. LPS induced a significant increase of TNF, IL-6, IL-l~and IL-12p40 levels compared to the control. Incubation ofBMDM with S. birrea inhibited LPS-dependent production of these cytokines ( Fig.  1 A, B , C and D). BMDM also produced abundant TNF, IL-6, IL-I~and IL-12p40 after infection with live M bovis BCG for 4 days. The production ofthese inflammatory cytokines was significantly reduced and in a concentration-dependent manner by S. birrea ( Fig. 2 A, B , C and D).
S. birrea extract inhibited NO production and iNOS expression by BMDM stimulated with LPS or infected with BCG
NO production was estimated by measuring nitrite in the BMDM culture media by the Griess method. Nitrite production was not modified in the To assess whether the anti-inflammatory effect of S. birrea is not due to its toxic ity, BMD M we re incubated with the plant extract in the presence or absence of LPS or M bovis BCG and the cell via bility was eva luated by crystal violet assay. The plant ext ract had no significant effect on macrophage via bility in the absence of stimuli ( Fig. 4 ). In the presence of either LPS or BCG, cell viability decreased at 24 h, as previously reported (19) . However, the three concentrations of S. birrea teste d did not show any effect on BMD M viability, indicating that the effects ofS. birrea on cytoki ne inhibition were not due to cel l death or toxic ity of the extract (Fig . 4) . were treated or not with S. birrea and LPS, followed by separation of cytoplamic and nuclear proteins and analysis ofNF-KB by western blot (Fig 6A) . We observed that S. birrea did not affect cytoplasmic NF-KB in the absence ofLPS. In contrast, incubation of LPS-treated RAW264. 7 with S. birrea decreased the NF-KB nuclear translocation (Fig. 6A) . These results were confirmed on S. birrea-treated BMOM that showed reduced nuclear translocation ofNF-KB at 30 mins after LPS (Fig. 6B ). We finally explored whether the same mechanism explained cytokine inhibition after BCG infection of S. birrea-treated BMOM and evaluated cytoplasmic and nuclear NF-KB at different time points after BCG . We observed that NF-KB nuclear translocation appeared after 5 h in BCG-infected BMOM, whereas S. birrea-treated BMDM NF-KB was undetectable at this time point (Fig. 6B ). .
Inhibition of
D-GaIN/LPS-induced inflammatory cytokines in mice: inhibition by S. birrea
Administration of LPS to D-GaIN-sensitized mice induces systemic release of pro-inflammatory cytokines mainly due to macrophages, T cells and hepatocytes (20) (21) . Mice were treated by oral administration of S. birrea (300 mg/kg) which has previously been tested for in vivo efficacy (22) . As shown in Fig. 7A , the serum level of TNF was reduced by 4. 16-fold 2 h after O-GalN/LPS injection by S. birrea (300 mglkg). Six hours after O-GaIN/ LPS, S. birrea (300 mglkg) exhibited a reduction of 2.2, 1.65 and 3.32 fold in TNF, IL-6 and IL-lP serum levels, respectively, (Fig. 7A, 7B and 7C) compared to the levels from control mice . These data show that serum levels of pro-inflammatory cytokines were reduced in a dose-dependent manner by S. birrea.
S. birrea inhibits NF-KB and iNOS activation. and protects from liver damage induced by D-GaIN/LPS
To study whether NF-KB activation was affected by treatment with S. birrea, mice were sacrificed 1 h after administration of O-GaIN/LPS-induced hepatitis for NF-KB immunohistochemistry studies. As shown in Fig. 8 (A and B) , control mice presented a majority ofNF-KB positive nuclear hepatocytes as well as macrophages, whereas S. birrea-treated mice exhibited a majority of negative nuclear hepatocyte (Fig. 8C) , which correlated with a limited liver injury, as observed by histological examination ofthe liver, compared to the control mice which exhibited death of hepatocytes and abundant mononuclear cell infiltration in hepatic sinusoids ( Fig.8D and 8E ). In addition, the liver of mice treated with S. birrea showed a reduction in iNOS immunostaining ( Fig. 8F and 8G) . These data indicate that S. birrea protects mice from D-GaIN/ LPS-induced liver failure. The observation of traditional treatment with S. birrea for inflammatory and infectious diseases suggests the possibility that this plant contains anti-inflammatory properties and can regulate inflammatory mediators. In the present investigation, we test the hypothesis that the effect of S. birrea observed for several clinical situations involves regulatory mechanisms at the level of cytokine activation on macrophages. Bone marrow-derived macrophages provide us with an excellent model for drug screening and for subsequent evaluation of the anti-inflammatory effects in vivo. We explored the effects of the stem bark methanol extract of S. birrea on pro-inflammatory molecules produced by BMDM stimulated with LPS and showed that cytokine production is decreased by S. birrea extract in a dose-dependent manner. The strongest inhibition was for LPS-induced IL-6, but TNF, Nitrite and iNOS were also significantly reduced by S. birrea. We were also interested in exploring the effects of S. birrea on macrophage infection with live mycobacteria. M bovis BCG recognition and phagocytosis by macrophages trigger the activation of a complex process involving many cytokines and inflammatory factors that mediate host immunity to mycobacterial infections. TNF production is critical for host immune responses and development of bactericidal mechanisms of macrophages to eliminate ingested bacilli (23) (24) . Analysis of the effect of S. birrea in M bovis BCG-activated macrophages showed a dosedependent inhibition of cytokines, confirming that this plant exerts modulation on macrophage cytokine expression. In the attempt to approach the molecular mechanisms involved in this immunoregulation, we studied the nuclear translocation of NF-KB after stimuli. The activation of macrophages by LPS is known to induce IKB phosphorylation and NF-KB nuclear translocation. NF-lCB plays a critical role in the regulation of genes involved in inflammatory responses including iNOS expression, TNF, IL-l p, IL-6, and IL-12p40 production (25) (26) . NF-KB nuclear translocation was reduced in LPS-stimulated RAW264.7 macrophage cell line and in BMDM treated with S. birrea, indicating that this pathway is implicated in the effect of the plant extract. Inhibition of NF-KB nuclear translocation was also observed in BCG-infected BMDM, suggesting that S. birrea interferes with this intracellular signalling.
DISCUSSION
LPS induces activation of many intracellular mediators and this needs more in depth studies to understand the pattern of intracellular signalling that can be modified by the presence of plant extract and to define the main effective compounds of the plant. S. birrea has been reported to contain phenolic On the basis of encouraging in vitro data confirming our hypothesis, we decided to explore further in vivo by using an animal model of hepatitis. Administration of D-GaIN/LPS induces an acute hepatitis in which cytokines and other inflammatory mediators released from macrophages and T cells play an important role (20) (21) . Our results showed that S. birrea inhibits cytokine and NF-KB nuclear translocation. Previous reports have shown that inhibition of NF-KB or c-Jun NH2-terminal kinase by specific inhibitor protected mice from D-GaIN/LPS-induced hepatic failure (28) (29) . Among inflammatory mediators, TNF plays a pivotal role and induces massive hepatocyte death (20) (21) (30) (31) (32) . The importance ofTNF was clearly demonstrated in studies using mice deficient in bioactive TNF and TNF knockout mice. These mice, . when sensitized with D-GaIN, exhibited resistance to LPS-induced lethality (14, 33 TNF but not membrane TNF appears to be required for lethality induced: by D-GaIN/LPS as shown protection in mouse only expressing a membrane form of TNF or membrane TNF knock in mice (34) . In this work, D-GaIN/LPS-induced hepatic failure was reduced in S. birrea-treated mice, as shown by reduced serum cytokine levels including TNF, transaminases and iNOS immunostaining. These in vivo results corroborate those observed in vitro on BMDM. In addition, we recently reported that S. birrea extracts posses anti-inflammatory activities in vivo, mediated by inhibition of histamine and prostaglandin liberation and/or activity, concomitant with anti-oxidant effects (22) .
In conclusion, we demonstrated that the stem bark methanol extract of S. birrea inhibited NO, TNF, IL-IP, IL-6 and IL-12p40 production by BMDM stimulated with LPS or infected with live M bovis BCG. The extract also inhibited pro-inflammatory cytokines and liver injury induced by D-GaIN/LPS in mice. These effects appears to be mediated by the inhibition of NF-KB activity but other effects cannot be excluded. Considering these results, the stem bark methanol extract of S. birrea modulates pro-inflammatory cytokines and may represent a potential new source of drugs for the treatment of inflammatory diseases. Further investigations are therefore obviously required to purify and identify the structure of the active compounds in this extract.
